Pulse Biosciences (PLSE) Competitors $17.68 +1.56 (+9.68%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends PLSE vs. IRMD, SPNE, UTMD, ARAY, CTSO, NVST, AXNX, NARI, LIVN, and ENOVShould you be buying Pulse Biosciences stock or one of its competitors? The main competitors of Pulse Biosciences include Iradimed (IRMD), SeaSpine (SPNE), Utah Medical Products (UTMD), Accuray (ARAY), Cytosorbents (CTSO), Envista (NVST), Axonics (AXNX), Inari Medical (NARI), LivaNova (LIVN), and Enovis (ENOV). These companies are all part of the "medical" sector. Pulse Biosciences vs. Iradimed SeaSpine Utah Medical Products Accuray Cytosorbents Envista Axonics Inari Medical LivaNova Enovis Pulse Biosciences (NASDAQ:PLSE) and Iradimed (NASDAQ:IRMD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, community ranking, dividends, valuation, institutional ownership and earnings. Is PLSE or IRMD more profitable? Iradimed has a net margin of 26.12% compared to Pulse Biosciences' net margin of 0.00%. Iradimed's return on equity of 23.99% beat Pulse Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Pulse BiosciencesN/A -96.89% -74.83% Iradimed 26.12%23.99%20.45% Do insiders and institutionals hold more shares of PLSE or IRMD? 77.0% of Pulse Biosciences shares are owned by institutional investors. Comparatively, 92.3% of Iradimed shares are owned by institutional investors. 71.5% of Pulse Biosciences shares are owned by insiders. Comparatively, 37.1% of Iradimed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more risk and volatility, PLSE or IRMD? Pulse Biosciences has a beta of 1.75, suggesting that its share price is 75% more volatile than the S&P 500. Comparatively, Iradimed has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500. Does the media refer more to PLSE or IRMD? In the previous week, Pulse Biosciences had 1 more articles in the media than Iradimed. MarketBeat recorded 1 mentions for Pulse Biosciences and 0 mentions for Iradimed. Pulse Biosciences' average media sentiment score of 0.61 beat Iradimed's score of 0.00 indicating that Pulse Biosciences is being referred to more favorably in the media. Company Overall Sentiment Pulse Biosciences Positive Iradimed Neutral Do analysts prefer PLSE or IRMD? Iradimed has a consensus target price of $60.00, indicating a potential upside of 12.72%. Given Iradimed's stronger consensus rating and higher probable upside, analysts plainly believe Iradimed is more favorable than Pulse Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Iradimed 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation & earnings, PLSE or IRMD? Iradimed has higher revenue and earnings than Pulse Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPulse Biosciences$700K1,553.82-$42.21MN/AN/AIradimed$65.56M10.29$17.19M$1.4636.46 Does the MarketBeat Community prefer PLSE or IRMD? Iradimed received 5 more outperform votes than Pulse Biosciences when rated by MarketBeat users. Likewise, 64.78% of users gave Iradimed an outperform vote while only 64.32% of users gave Pulse Biosciences an outperform vote. CompanyUnderperformOutperformPulse BiosciencesOutperform Votes24764.32% Underperform Votes13735.68% IradimedOutperform Votes25264.78% Underperform Votes13735.22% SummaryIradimed beats Pulse Biosciences on 11 of the 16 factors compared between the two stocks. Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLSE vs. The Competition Export to ExcelMetricPulse BiosciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.09B$4.51B$5.20B$8.85BDividend YieldN/A45.94%5.53%4.08%P/E RatioN/A16.5679.4715.17Price / Sales1,553.8245.891,246.7687.28Price / CashN/A55.6440.9036.92Price / Book13.715.987.196.55Net Income-$42.21M$13.99M$119.54M$226.22M7 Day Performance6.25%3.35%2.12%3.77%1 Month Performance4.99%4.71%-2.43%4.64%1 Year Performance164.28%47.22%34.52%29.21% Pulse Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLSEPulse Biosciences1.6333 of 5 stars$17.68+9.7%N/A+164.3%$1.09B$700,000.000.00140IRMDIradimed4.5391 of 5 stars$53.04-0.4%$60.00+13.1%+30.5%$672.18M$71.31M36.46110SPNESeaSpineN/A$9.54flatN/A+0.0%$354.92M$191.45M-5.39523Analyst ForecastGap DownUTMDUtah Medical Products3.4932 of 5 stars$65.45+1.4%N/A-20.8%$221.88M$50.22M15.12180Positive NewsARAYAccuray4.7291 of 5 stars$1.91+1.0%$9.00+371.4%-29.8%$192.01M$446.55M-11.21987Analyst RevisionNews CoverageCTSOCytosorbents1.2592 of 5 stars$0.95+6.7%$2.00+110.5%-25.8%$51.95M$36.35M-2.49186NVSTEnvista3.6836 of 5 stars$21.37-0.1%$20.71-3.1%-10.4%$3.68B$2.57B-2.7512,800AXNXAxonics3.3 of 5 stars$70.98flat$71.00+0.0%N/A$3.63B$366.38M-591.45610NARIInari Medical3.3115 of 5 stars$49.97+0.4%$58.89+17.8%-15.9%$2.93B$493.63M-36.891,300Insider TradeNews CoveragePositive NewsLIVNLivaNova3.9175 of 5 stars$50.76-1.8%$69.17+36.3%+16.5%$2.76B$1.15B123.102,900Positive NewsENOVEnovis3.3991 of 5 stars$46.66+1.1%$67.00+43.6%-8.1%$2.61B$1.71B-21.136,550News CoveragePositive News Related Companies and Tools Related Companies IRMD Competitors SPNE Competitors UTMD Competitors ARAY Competitors CTSO Competitors NVST Competitors AXNX Competitors NARI Competitors LIVN Competitors ENOV Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PLSE) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PLSE Stock Alerts